The short version
6 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Hemangeol
propranolol hydrochloride · PROPRANOLOL HYDROCHLORIDE 4.28 mg/mL · Solution · Oral · Pierre Fabre Pharmaceuticals, Inc.
NDC 64370-0375-01 · 1 BOTTLE, GLASS in 1 CARTON / 120 mL in 1 BOTTLE, GLASS · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$625.38
Reported to Texas DSHS · 2026 annual filing · Pierre-fabre Pharmaceuticals
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicaid spend (2025)
$7.8M
10,124 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for propranolol hydrochloride (other) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- NDA205410
- TE code
- —
- Approval date
- Mar 14, 2014
- Patents / exclusivity
- 2 patents, 0 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| patent | 8338489 | Oct 16, 2028 |
| patent | 8987262 | Oct 16, 2028 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of propranolol hydrochloride (Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Eton Pharmaceuticals, Inc. | PROPRANOLOL HYDROCHLORIDE 4.28 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | PROPRANOLOL HYDROCHLORIDE 20 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | PROPRANOLOL HYDROCHLORIDE 40 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Pharmaceutical Associates, Inc. | PROPRANOLOL HYDROCHLORIDE 20 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Pierre Fabre Pharmaceuticals, Inc. | PROPRANOLOL HYDROCHLORIDE 4.28 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| PAI Holdings, LLC dba PAI Pharma | PROPRANOLOL HYDROCHLORIDE 20 mg/5mL | Aug 26, 2026 | Aug 31, 2026 |
| Atlantic Biologicals Corp. | PROPRANOLOL HYDROCHLORIDE 20 mg/5mL | Jul 15, 2026 | Aug 28, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Hemangeol — NDC 64370-0375-01," retrieved September 3, 2026, https://drugdashboards.com/drug/64370037501.
Free to cite with attribution — see how the data is put together.